Recent Articles

5 Big Pharma Stocks to Buy (And 2 Busts to Avoid!)

Several Big Pharma names are worthy buys right now, but a couple of pharmaceutical stocks may be best left avoided. More 

Wall Street Slides Lower in Pre-Holiday Trading

Stocks moved lower on Wall Street today, with consumer staples leading the way and telecom bringing up the rear. Crude saw some overnight volatility, while Pfizer made headlines with an inversion deal with Allergan. More 

Market Underestimates Pfizer Stock After Allergan Deal

Pfizer stock has been falling on rumors, and then official reports, of a buyout of Allergan, but there's no real downside to this pairing. More 

Monday’s Vital Data: Apple Inc. (AAPL), Pfizer, Inc. (PFE) and National Bank of Greece (NBG)

Apple (AAPL) calls up on China data. Pfizer (PFE) speculation ahead of Allergan (AGN) deal. National Bank of Greece (NBG) pummeled by puts. More 

Pfizer Stock Down, But Hardly Out, On Threats to Tax Inversion Law

Pfizer stock took a hit on concerns that it's union with Allergan could be upended by new tax rules in the meantime, but the odds still favor PFE. More 

Thursday’s Vital Data: Apple Inc. (AAPL), Qualcomm, Inc. (QCOM) and Pfizer Inc. (PFE)

Apple (AAPL) supplier Foxconn's revenue points to strong iPhone sales, while Qualcomm (QCOM) faces antitrust in Korea and Pfizer (PFE) nears a deal with Allergan (AGN). More 

7 Best Index Funds to Hold for the Next Decade

These mutual funds and ETFs could be the best index funds to hold over the coming decade. More